Which adverse effect is commonly associated with statin therapy?

Study for the Anticoagulation and ACS Exam with tailored flashcards and multiple choice questions, each featuring hints and detailed explanations. Prepare effectively and ensure success on your exam with confidence!

Multiple Choice

Which adverse effect is commonly associated with statin therapy?

Explanation:
Muscle-related effects are a well-known concern with statins, and the most commonly reported adverse effect is myalgia—that sense of muscle pain or weakness that patients often notice in the legs or proximal muscles. This occurs more frequently than true liver injury or electrolyte disturbances, and while mild liver enzyme elevations can happen, significant hepatotoxicity is uncommon and usually resolves if the drug is stopped. Hyperkalemia is not typically linked to statins, and headaches, though possible, are nonspecific and not characteristic of statin therapy. Therefore, myalgia best matches the common adverse effect pattern seen with statins. If symptoms are mild, continuing with observation and routine monitoring is reasonable; for more severe or persistent symptoms, reassessment of dose or switching statins may be warranted, and CK levels can be checked if muscle symptoms are concerning.

Muscle-related effects are a well-known concern with statins, and the most commonly reported adverse effect is myalgia—that sense of muscle pain or weakness that patients often notice in the legs or proximal muscles. This occurs more frequently than true liver injury or electrolyte disturbances, and while mild liver enzyme elevations can happen, significant hepatotoxicity is uncommon and usually resolves if the drug is stopped. Hyperkalemia is not typically linked to statins, and headaches, though possible, are nonspecific and not characteristic of statin therapy. Therefore, myalgia best matches the common adverse effect pattern seen with statins. If symptoms are mild, continuing with observation and routine monitoring is reasonable; for more severe or persistent symptoms, reassessment of dose or switching statins may be warranted, and CK levels can be checked if muscle symptoms are concerning.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy